Clinical Trials Insight: 700015961
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2007
At a glance
- Drugs AVE 1642 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- Sponsors Sanofi
- 12 Dec 2007 Positive results were presented at the 49th annual meeting of the American Society of Hematology (ASH).
- 09 Dec 2007 Status changed from inititated to in progress.
- 27 Nov 2007 Results to be presented at ASH 2007.